Characteristics of import and export trade of Chinese traditional medicine in 2009

In 2009, the import and export performance of Chinese herbal medicines was outstanding, with the import and export volume reaching US $650 million, up 7.2% year on year Among them, the export volume was US $550 million, up 6.4% year on year; the import volume was US $90 million, up 12.2% year on year, basically maintaining a stable growth However, the export situation in the first half of the year and the second half of the year is obviously different, which can be called "ice and fire double sky": the export in the first half of the year is obviously weak, the export volume in January dropped by 30% year on year; the second half of the year began to rebound strongly, and the export volume in December rose by 30% year on year At the beginning of the year and the end of the year, the two opposite market patterns reflect that the export of Chinese herbal medicines and pieces of decoction has recovered from a low point, especially in the second half of 2009, the monthly export volume of Chinese herbal medicines and pieces of decoction has reached a new high In 2009, the export volume of Chinese medicinal materials and pieces of crude drugs increased significantly year on year The export volume of wolfberry, Cordyceps sinensis, chrysanthemum and Atractylodes macrocephala increased by more than 50% The biggest increase was cumin, with export volume and export volume increasing by more than 300% The main export market of Chinese herbal medicines in China is Asia, among which Hong Kong, Japan and Vietnam are the main markets The total export volume of the three markets accounts for more than half of the total export volume of Chinese herbal medicines In 2009, there were 1000 enterprises exporting Chinese herbal medicine and decoction pieces in China, but only 7 enterprises exporting more than US $10 million, ranking in the top five: Guangxi Ningming import and Export Trade Corporation, China Medical and Health Products Co., Ltd., Shenzhen Jincun Pharmaceutical Co., Ltd., Bozhou boguang Chinese herbal medicine decoction pieces Co., Ltd and Sichuan Chuancun Chinese Herbal Medicine Co., Ltd Plant extract: with strong growth, it has become the main plant extract driving the export of traditional Chinese medicine, which is the most outstanding commodity category in the import and export of traditional Chinese medicine in 2009, with the import and export volume reaching US $820 million, an increase of 36.1% year on year Among them, the export reached US $660 million, an increase of 23.7% year on year; the import reached US $160 million, an increase of 129.2% year on year The export volume accounts for 44.8% of the total export volume of traditional Chinese medicine, which is the driving force to promote the export of traditional Chinese medicine From the perspective of export product structure, the largest increase in export amount is natural pigment products The export amount of Stevia extract increased significantly In 2009, the export amount of Stevia extract reached US $84.3 million, up 132% year on year China's plant extract industry has a certain cluster effect, and the plant extract industry in each province has its own characteristics For example, Shandong Province mainly produces plant extracts for food additives, while Zhejiang and Shanghai mainly produce plant extracts for medicinal and health products According to statistics, in 2009, the export volume of food additives and fragrances and plant extracts were mainly increased, such as Shandong and Jiangxi The export of Stevia extract increased greatly, and the export of Yunnan flavors and fragrances increased significantly Provinces and cities that mainly export plant extracts for medicinal and health products, such as Zhejiang and Beijing, saw a slight decline in export volume In 2009, the main export markets of plant extracts in China are still Japan and the United States The Japanese market is relatively stable, and the price and quantity of plant extracts have maintained a steady increase Most of the plant extracts imported from Japan are extracted and produced by the enterprises invested by Japanese Chinese medicine enterprises in China, such as Kimura, Japan, etc China's export of plant extracts to the U.S market increased significantly year-on-year, mainly because the price of extracts exported to the U.S increased significantly, with an average increase of 49.5% The export market of other plant extracts is more eye-catching in India and Malaysia, with a year-on-year growth of more than 100% Both markets are driven by a sharp rise in exports of a single commodity Most of the commodities exported to India are concentrated in natural plant extracts, such as natural pigments, flavors and fragrances More than 90% of the commodities exported to Malaysia are Stevia extract, which are widely used in food industry Chinese patent medicine: import and export shrank at the same time The trade deficit still reached 12.42 million US dollars in 2009 The cumulative import and export volume of Chinese patent medicine reached 339 million US dollars, down 4% year on year Among them, the export value was US $160 million, down 4.23% year on year; the import value was US $176 million, down 3.88% year on year In 2009, the trade deficit of Chinese patent medicine was 12.42 million US dollars, basically equivalent to the deficit of 12.28 million US dollars in 2008 In 2009, China's exports of Chinese patent medicines to 95 countries and regions, of which South Korea, Benin and Vietnam are the markets with larger export growth; Indonesia, Ghana, the United Arab Emirates, Canada and the United Kingdom are the markets with more export decline The main export markets of Chinese patent medicine in China are still Hong Kong, Japan and the United States, which together account for about 57% of the export of Chinese patent medicine in China Hong Kong is the largest market for the export of Chinese patent medicines in China In 2009, the export of Chinese patent medicines reached US $67.34 million, an increase of about 6% year on year There are two main reasons: first, there is a strong demand for Chinese patent medicines in Hong Kong; second, some Hong Kong merchants have branches in the United States, Europe and other countries, and Hong Kong has become a transit station for the export of Chinese patent medicines to the world In 2009, China's export volume of "Chinese patent medicine" to Japan decreased by 22% year on year, and the export amount was 14.62 million US dollars, down 9.5% year on year In addition, at the end of 2009, the Japanese government's budget screening working group plans to exclude Chinese medicine from the application of public health insurance If this plan is implemented, it means that Japanese medicine, which has been used as medical insurance medicine since 1976, may become self funded medicine in Japan, which will have a certain impact on the export of Chinese patent medicine to Japan in the future, and it deserves our long-term attention In 2009, China's export volume of "Chinese patent medicine" to the EU dropped by 19% year on year, and the export amount was US $10.26 million, down 18% year on year The transition period of EU's "traditional botanical medicine registration procedure directive" will come to an end Up to now, no Chinese patent medicine has passed the EU's simple registration in China This means that since April 2011, the sales of Chinese traditional medicine in the EU will be strictly managed, which will have a greater impact on the future export of Chinese traditional medicine to the EU market In 2009, there were 661 Chinese patent medicine export enterprises in China, a decrease of 8% over the same period of last year State owned enterprises are still the main part of the export of Chinese patent medicine, with the annual export reaching US $95.88 million, accounting for 59% of the total export of Chinese patent medicine, down 0.5% compared with the same period last year Because state-owned Chinese patent medicine enterprises and their products have high brand reputation, large production scale, independent product intellectual property rights and relatively fixed market consumers, the export of state-owned Chinese patent medicine enterprises has been relatively stable In 2009, the top three export companies of Chinese patent medicine were Beijing Tongrentang Co., Ltd., Zhangzhou Pianzihuang Pharmaceutical Co., Ltd and Guangzhou Pharmaceutical Import and export company Health care products: they are not warm and hot In 2009, the import and export of health care products increased on a par The cumulative import and export volume of health care products in China reached US $200 million, up 3.1% year on year Among them, the export volume reached US $89.1 million, a year-on-year increase of 2.2%; the import volume reached US $110 million, a year-on-year increase of 3.9% The main export markets of China's health products are Japan and the United States, which account for more than 60% of China's health products exports In 2009, exports to Asia showed negative growth for the first time, while exports to traditional markets such as North America and the European Union continued to increase China's health products have been exported to 80 countries and regions in the world, of which Vietnam, Canada, the Russian Federation and the Netherlands have seen a large increase in exports; Indonesia, Malaysia, Australia, South Korea and Hong Kong have seen a large decline in exports In 2009, China's exports of health care products were mainly fish oil, seaweed and royal jelly products The main export provinces were Zhejiang, Guangdong, Shandong and Jiangsu The export growth of Anhui, Qinghai and Guangdong was relatively fast, while the export of Beijing and Sichuan dropped a lot Three capital and private enterprises are the main force of health products export, accounting for 86% of China's health products export (medical insurance chamber of Commerce arranges according to the data of China Customs)